“Dupilumab Improves Disease Control and Patient-Reported Outcomes in Adults with Atopic Dermatitis in Clinical Practice: Subgroup Analysis of Black/African American Population from RELIEVE-AD” (2024) SKIN The Journal of Cutaneous Medicine, 8(1), p. s327. doi:10.25251/skin.8.supp.327.